Rifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study

E-ISSN： 1872-034x|48|1|69-77

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.48, Iss.1, 2018-01, pp. : 69-77

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liraglutide for NASH/NAFLD

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 269-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human placental extract treatment for non‐alcoholic steatohepatitis non‐responsive to lifestyle intervention: A pilot study

HEPATOLOGY RESEARCH, Vol. 45, Iss. 9, 2015-09 ,pp. : 1034-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Open‐label pilot study of interferon gamma‐1b in Friedreich ataxia

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 1, 2015-07 ,pp. : 7-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

An open-label evaluation of rifaximin in the treatment of active Crohn's disease

By Shafran Ira Johnson Lorin K.

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1165-1170

Informa Healthcare

Access to resources Recommend Favorite

Repetitive transcranial magnetic stimulation for hemispatial neglect in patients after stroke: An open-label pilot study

By Lim Jong Youb Kang Eun Kyoung Paik Nam-Jong

Journal of Rehabilitation Medicine, Vol. 42, Iss. 5, 2010-05 ,pp. : 447-452

Medical Journals Limited

Access to resources Recommend Favorite